Rank | Gene Set | Z-score |
---|---|---|
1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.97859049 |
2 | intestinal cholesterol absorption (GO:0030299) | 6.82214346 |
3 | intestinal absorption (GO:0050892) | 6.62039395 |
4 | L-phenylalanine catabolic process (GO:0006559) | 5.89618192 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.89618192 |
6 | regulation of cholesterol esterification (GO:0010872) | 5.73857475 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.73439322 |
8 | L-phenylalanine metabolic process (GO:0006558) | 5.73439322 |
9 | regulation of triglyceride catabolic process (GO:0010896) | 5.71152267 |
10 | phospholipid efflux (GO:0033700) | 5.58433153 |
11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.55386164 |
12 | urea cycle (GO:0000050) | 5.39458188 |
13 | urea metabolic process (GO:0019627) | 5.39458188 |
14 | aromatic amino acid family catabolic process (GO:0009074) | 5.34699522 |
15 | drug catabolic process (GO:0042737) | 5.14962756 |
16 | reverse cholesterol transport (GO:0043691) | 5.12838201 |
17 | negative regulation of sterol transport (GO:0032372) | 4.98674627 |
18 | negative regulation of cholesterol transport (GO:0032375) | 4.98674627 |
19 | plasma lipoprotein particle assembly (GO:0034377) | 4.92353145 |
20 | nitrogen cycle metabolic process (GO:0071941) | 4.92271990 |
21 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.91109301 |
22 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.91109301 |
23 | cholesterol efflux (GO:0033344) | 4.90796260 |
24 | indole-containing compound catabolic process (GO:0042436) | 4.89697537 |
25 | indolalkylamine catabolic process (GO:0046218) | 4.89697537 |
26 | tryptophan catabolic process (GO:0006569) | 4.89697537 |
27 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83178456 |
28 | protein-lipid complex remodeling (GO:0034368) | 4.83178456 |
29 | macromolecular complex remodeling (GO:0034367) | 4.83178456 |
30 | sulfur amino acid catabolic process (GO:0000098) | 4.82566272 |
31 | kynurenine metabolic process (GO:0070189) | 4.77688445 |
32 | regulation of bile acid biosynthetic process (GO:0070857) | 4.76857254 |
33 | cysteine metabolic process (GO:0006534) | 4.75424448 |
34 | bile acid biosynthetic process (GO:0006699) | 4.72521027 |
35 | bile acid and bile salt transport (GO:0015721) | 4.72455951 |
36 | cellular glucuronidation (GO:0052695) | 4.67699318 |
37 | homocysteine metabolic process (GO:0050667) | 4.66416022 |
38 | regulation of pigment cell differentiation (GO:0050932) | 4.62182637 |
39 | tryptophan metabolic process (GO:0006568) | 4.59405550 |
40 | alpha-linolenic acid metabolic process (GO:0036109) | 4.59391232 |
41 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.57295487 |
42 | glyoxylate metabolic process (GO:0046487) | 4.52419626 |
43 | protein-lipid complex assembly (GO:0065005) | 4.49905738 |
44 | bile acid metabolic process (GO:0008206) | 4.44400366 |
45 | triglyceride homeostasis (GO:0070328) | 4.40954959 |
46 | acylglycerol homeostasis (GO:0055090) | 4.40954959 |
47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36155118 |
48 | angiotensin maturation (GO:0002003) | 4.34243195 |
49 | cholesterol homeostasis (GO:0042632) | 4.32228872 |
50 | lipoprotein metabolic process (GO:0042157) | 4.27510407 |
51 | sterol homeostasis (GO:0055092) | 4.25934404 |
52 | phospholipid translocation (GO:0045332) | 4.21605910 |
53 | lipid translocation (GO:0034204) | 4.21605910 |
54 | uronic acid metabolic process (GO:0006063) | 4.21492678 |
55 | glucuronate metabolic process (GO:0019585) | 4.21492678 |
56 | amino-acid betaine metabolic process (GO:0006577) | 4.06898825 |
57 | negative regulation of fibrinolysis (GO:0051918) | 4.02534875 |
58 | regulation of cholesterol homeostasis (GO:2000188) | 4.02397249 |
59 | plasma lipoprotein particle clearance (GO:0034381) | 4.02067676 |
60 | lysine catabolic process (GO:0006554) | 4.00504318 |
61 | lysine metabolic process (GO:0006553) | 4.00504318 |
62 | establishment of protein localization to Golgi (GO:0072600) | 3.98759970 |
63 | positive regulation of lipid catabolic process (GO:0050996) | 3.98044922 |
64 | protein carboxylation (GO:0018214) | 3.96977744 |
65 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.96977744 |
66 | complement activation, alternative pathway (GO:0006957) | 3.96136485 |
67 | regulation of establishment of cell polarity (GO:2000114) | 3.94338736 |
68 | plasma lipoprotein particle organization (GO:0071827) | 3.93208591 |
69 | regulation of protein activation cascade (GO:2000257) | 3.92853821 |
70 | serine family amino acid catabolic process (GO:0009071) | 3.92011480 |
71 | regulation of fibrinolysis (GO:0051917) | 3.90881703 |
72 | exogenous drug catabolic process (GO:0042738) | 3.88864318 |
73 | aromatic amino acid family metabolic process (GO:0009072) | 3.87694988 |
74 | protein K11-linked deubiquitination (GO:0035871) | 3.86222504 |
75 | phospholipid homeostasis (GO:0055091) | 3.83491029 |
76 | cellular ketone body metabolic process (GO:0046950) | 3.79779975 |
77 | positive regulation of developmental pigmentation (GO:0048087) | 3.78633978 |
78 | protein K48-linked deubiquitination (GO:0071108) | 3.76508601 |
79 | drug metabolic process (GO:0017144) | 3.76402958 |
80 | protein-lipid complex subunit organization (GO:0071825) | 3.74958133 |
81 | cholesterol transport (GO:0030301) | 3.68687611 |
82 | sterol transport (GO:0015918) | 3.68687611 |
83 | regulation of complement activation (GO:0030449) | 3.67485879 |
84 | response to nitrosative stress (GO:0051409) | 3.67333800 |
85 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.65494284 |
86 | * flavonoid metabolic process (GO:0009812) | 3.64997234 |
87 | neural tube formation (GO:0001841) | 3.64996741 |
88 | benzene-containing compound metabolic process (GO:0042537) | 3.62700250 |
89 | interkinetic nuclear migration (GO:0022027) | 3.62495823 |
90 | drug transmembrane transport (GO:0006855) | 3.61722265 |
91 | alpha-amino acid catabolic process (GO:1901606) | 3.61201424 |
92 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.60832912 |
93 | tyrosine metabolic process (GO:0006570) | 3.58849193 |
94 | arginine metabolic process (GO:0006525) | 3.58539032 |
95 | glutamate metabolic process (GO:0006536) | 3.56990248 |
96 | L-fucose catabolic process (GO:0042355) | 3.53549242 |
97 | fucose catabolic process (GO:0019317) | 3.53549242 |
98 | L-fucose metabolic process (GO:0042354) | 3.53549242 |
99 | epoxygenase P450 pathway (GO:0019373) | 3.52425074 |
100 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.51976435 |
101 | ethanol oxidation (GO:0006069) | 3.50019385 |
102 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.47913346 |
103 | indolalkylamine metabolic process (GO:0006586) | 3.45184831 |
104 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.43639721 |
105 | hormone catabolic process (GO:0042447) | 3.43515204 |
106 | low-density lipoprotein particle remodeling (GO:0034374) | 3.43156168 |
107 | cellular amino acid catabolic process (GO:0009063) | 3.41400001 |
108 | cellular modified amino acid catabolic process (GO:0042219) | 3.38717728 |
109 | coenzyme catabolic process (GO:0009109) | 3.37622360 |
110 | xenobiotic catabolic process (GO:0042178) | 3.37618581 |
111 | lipid homeostasis (GO:0055088) | 3.37500962 |
112 | amine catabolic process (GO:0009310) | 3.34956550 |
113 | cellular biogenic amine catabolic process (GO:0042402) | 3.34956550 |
114 | negative regulation of lipase activity (GO:0060192) | 3.32770693 |
115 | drug transport (GO:0015893) | 3.31840827 |
116 | alkaloid metabolic process (GO:0009820) | 3.29893838 |
117 | signal peptide processing (GO:0006465) | 3.27563524 |
118 | cellular response to ethanol (GO:0071361) | 3.25282407 |
119 | negative regulation of sodium ion transport (GO:0010766) | 3.22604971 |
120 | oxidative demethylation (GO:0070989) | 3.21309311 |
121 | snRNA transcription (GO:0009301) | 3.15008815 |
122 | protein targeting to lysosome (GO:0006622) | 3.10705330 |
123 | establishment of protein localization to vacuole (GO:0072666) | 3.10705330 |
124 | protein targeting to vacuole (GO:0006623) | 3.10705330 |
125 | NAD biosynthetic process (GO:0009435) | 3.08849232 |
126 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.07113953 |
127 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.07113953 |
128 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.07113953 |
129 | protein K63-linked deubiquitination (GO:0070536) | 3.05563450 |
130 | striated muscle atrophy (GO:0014891) | 3.04047553 |
131 | behavioral response to nicotine (GO:0035095) | 2.94463731 |
132 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.92420246 |
133 | regulation of hippo signaling (GO:0035330) | 2.90700165 |
134 | disruption of cells of other organism (GO:0044364) | 2.88563682 |
135 | killing of cells of other organism (GO:0031640) | 2.88563682 |
136 | endosome to pigment granule transport (GO:0043485) | 2.85899081 |
137 | endosome to melanosome transport (GO:0035646) | 2.85899081 |
138 | negative regulation of protein localization to cell surface (GO:2000009) | 2.84746778 |
139 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.84656414 |
140 | regulation of guanylate cyclase activity (GO:0031282) | 2.84052901 |
141 | sulfate transmembrane transport (GO:1902358) | 2.82151408 |
142 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.80162748 |
143 | serotonin metabolic process (GO:0042428) | 2.76138298 |
144 | indole-containing compound metabolic process (GO:0042430) | 2.74704355 |
145 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74434141 |
146 | skeletal muscle adaptation (GO:0043501) | 2.71950220 |
147 | proline transport (GO:0015824) | 2.69250796 |
148 | regulation of membrane lipid distribution (GO:0097035) | 2.69237295 |
149 | cardiovascular system development (GO:0072358) | 2.68358958 |
150 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.67429524 |
151 | regulation of developmental pigmentation (GO:0048070) | 2.65282057 |
152 | primary amino compound metabolic process (GO:1901160) | 2.62356125 |
153 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.61678214 |
154 | activated T cell proliferation (GO:0050798) | 2.58288847 |
155 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.58093025 |
156 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.57448922 |
157 | detection of light stimulus involved in visual perception (GO:0050908) | 2.57448922 |
158 | regulation of sarcomere organization (GO:0060297) | 2.56802501 |
159 | positive regulation of fatty acid oxidation (GO:0046321) | 2.56031316 |
160 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.55712722 |
161 | protein targeting to Golgi (GO:0000042) | 2.55510351 |
162 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.54288756 |
163 | reflex (GO:0060004) | 2.53927580 |
164 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.53506791 |
165 | defense response to fungus (GO:0050832) | 2.49015300 |
166 | negative regulation of mast cell activation (GO:0033004) | 2.47481517 |
167 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.44384725 |
168 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.43301826 |
169 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.43301826 |
170 | macroautophagy (GO:0016236) | 2.42258120 |
171 | regulation of gene silencing by miRNA (GO:0060964) | 2.41514126 |
172 | regulation of gene silencing by RNA (GO:0060966) | 2.41514126 |
173 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.41514126 |
174 | endocardial cushion development (GO:0003197) | 2.40514889 |
175 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.38480071 |
176 | pericardium development (GO:0060039) | 2.38006776 |
177 | sulfate transport (GO:0008272) | 2.36015182 |
178 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.35531974 |
179 | photoreceptor cell maintenance (GO:0045494) | 2.34831405 |
180 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.33375334 |
181 | rRNA catabolic process (GO:0016075) | 2.31794029 |
182 | muscle atrophy (GO:0014889) | 2.31577817 |
183 | gamma-aminobutyric acid transport (GO:0015812) | 2.30296349 |
184 | kidney morphogenesis (GO:0060993) | 2.27212166 |
185 | neuronal action potential (GO:0019228) | 2.26406871 |
186 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.26171932 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.20300352 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.46941871 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.01847659 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.87481408 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.39696610 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.21426740 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.15395668 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.58152968 |
9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.52681809 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.00960645 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.81069021 |
12 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.80623416 |
13 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.68540111 |
14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.62694264 |
15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.38208665 |
16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.31119984 |
17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.31042636 |
18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.27221087 |
19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15474473 |
20 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.14873794 |
21 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06805779 |
22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.04749311 |
23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.03852015 |
24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03092992 |
25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1437111 |
26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99590688 |
27 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.97190201 |
28 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.96563902 |
29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91190809 |
30 | TP53_16413492_ChIP-PET_HCT116_Human | 1.83011732 |
31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.77493905 |
32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77341823 |
33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76218681 |
34 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.74419758 |
35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73043121 |
36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.73036158 |
37 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72821606 |
38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.69451980 |
39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68704337 |
40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68697239 |
41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62382376 |
42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.59505813 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59407803 |
44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57974306 |
45 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.55643580 |
46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53684019 |
47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53335311 |
48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52947943 |
49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52628279 |
50 | TCF4_23295773_ChIP-Seq_U87_Human | 1.51112589 |
51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47963385 |
52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47425815 |
53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46812032 |
54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.45474308 |
55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.42348391 |
56 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.41775531 |
57 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.39217236 |
58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39206598 |
59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38801007 |
60 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.38295650 |
61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36017939 |
62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35208518 |
63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34975312 |
64 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33421412 |
65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32981128 |
66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32477641 |
67 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32016253 |
68 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32016253 |
69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31970916 |
70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31691294 |
71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30858551 |
72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30321403 |
73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28068985 |
74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28068985 |
75 | RXR_22108803_ChIP-Seq_LS180_Human | 1.25192118 |
76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23858187 |
77 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23791473 |
78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22755805 |
79 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.22613961 |
80 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.22391200 |
81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19281340 |
82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18062516 |
83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17774076 |
84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17560760 |
85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16480500 |
86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16459596 |
87 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.14795567 |
88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13047460 |
89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11735614 |
90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11697341 |
91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11322654 |
92 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10859574 |
93 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09519458 |
94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09273658 |
95 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08585447 |
96 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08063230 |
97 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07884695 |
98 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06349900 |
99 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.06060438 |
100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05936948 |
101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04119664 |
102 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03953775 |
103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03093703 |
104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02311925 |
105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02191238 |
106 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01756911 |
107 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01711860 |
108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00946602 |
109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00737571 |
110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00331723 |
111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00302645 |
112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99598675 |
113 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97736702 |
114 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97406602 |
115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97361336 |
116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96971036 |
117 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96820710 |
118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95312317 |
119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94848970 |
120 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.93882603 |
121 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93251160 |
122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92566554 |
123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91721115 |
124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89183211 |
125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88553693 |
126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88154958 |
127 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87139359 |
128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87012363 |
129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86868171 |
130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86857048 |
131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86336882 |
132 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83564305 |
133 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78330049 |
134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78011870 |
135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77965818 |
136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77739427 |
137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76402998 |
138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.76277315 |
139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75419149 |
140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75099588 |
141 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73260502 |
142 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72479016 |
143 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.72081984 |
144 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71681575 |
145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70467227 |
146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68419830 |
147 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.68157632 |
148 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68140904 |
149 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67795962 |
150 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67795962 |
151 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67143693 |
152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.65649146 |
153 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.64780393 |
154 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64564766 |
155 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.64559831 |
156 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.63594859 |
157 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63305662 |
158 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.63285229 |
159 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.62363080 |
160 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.61137443 |
161 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.60832726 |
162 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59682920 |
163 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59669871 |
164 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.59651565 |
165 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.59086462 |
166 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.58908814 |
167 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57687517 |
168 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.57677942 |
169 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.57260530 |
170 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.56908282 |
171 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56666521 |
172 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.56568654 |
173 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56451560 |
174 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53638112 |
175 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.52708972 |
176 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.51971385 |
177 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.50371177 |
178 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.49813159 |
179 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49791862 |
180 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49142583 |
181 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.48830659 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.87529210 |
2 | MP0002139_abnormal_hepatobiliary_system | 7.19378000 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.98203449 |
4 | MP0000569_abnormal_digit_pigmentation | 5.28343642 |
5 | MP0005365_abnormal_bile_salt | 5.24000702 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.06367609 |
7 | MP0001666_abnormal_nutrient_absorption | 4.31924696 |
8 | MP0003252_abnormal_bile_duct | 4.09006899 |
9 | MP0009840_abnormal_foam_cell | 3.86776665 |
10 | MP0003806_abnormal_nucleotide_metabolis | 3.66199758 |
11 | MP0010329_abnormal_lipoprotein_level | 3.50885771 |
12 | MP0008057_abnormal_DNA_replication | 2.62730787 |
13 | MP0001501_abnormal_sleep_pattern | 2.52727319 |
14 | MP0003646_muscle_fatigue | 2.44005061 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.35562264 |
16 | MP0005332_abnormal_amino_acid | 2.33224798 |
17 | MP0003724_increased_susceptibility_to | 2.23145543 |
18 | MP0005083_abnormal_biliary_tract | 2.14784969 |
19 | MP0000427_abnormal_hair_cycle | 2.12040053 |
20 | MP0005174_abnormal_tail_pigmentation | 2.08944020 |
21 | MP0005310_abnormal_salivary_gland | 2.04095957 |
22 | MP0003191_abnormal_cellular_cholesterol | 2.03863186 |
23 | MP0003045_fibrosis | 1.99497678 |
24 | MP0009697_abnormal_copulation | 1.91411412 |
25 | MP0000609_abnormal_liver_physiology | 1.84201551 |
26 | MP0002118_abnormal_lipid_homeostasis | 1.83255215 |
27 | MP0008961_abnormal_basal_metabolism | 1.80388086 |
28 | MP0004130_abnormal_muscle_cell | 1.73926313 |
29 | MP0002009_preneoplasia | 1.71093578 |
30 | MP0003868_abnormal_feces_composition | 1.66521221 |
31 | MP0010234_abnormal_vibrissa_follicle | 1.64356025 |
32 | MP0003195_calcinosis | 1.59689700 |
33 | MP0005551_abnormal_eye_electrophysiolog | 1.58742129 |
34 | MP0005319_abnormal_enzyme/_coenzyme | 1.57290229 |
35 | MP0005670_abnormal_white_adipose | 1.56160170 |
36 | MP0004264_abnormal_extraembryonic_tissu | 1.54407490 |
37 | MP0009046_muscle_twitch | 1.49243276 |
38 | MP0001764_abnormal_homeostasis | 1.48246080 |
39 | MP0002822_catalepsy | 1.43334183 |
40 | MP0000383_abnormal_hair_follicle | 1.42383601 |
41 | MP0001485_abnormal_pinna_reflex | 1.35620644 |
42 | MP0002138_abnormal_hepatobiliary_system | 1.32249412 |
43 | MP0001968_abnormal_touch/_nociception | 1.30291361 |
44 | MP0001800_abnormal_humoral_immune | 1.29706223 |
45 | MP0009643_abnormal_urine_homeostasis | 1.27430313 |
46 | MP0000462_abnormal_digestive_system | 1.26427660 |
47 | MP0005084_abnormal_gallbladder_morpholo | 1.25858185 |
48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24959655 |
49 | MP0005451_abnormal_body_composition | 1.24012359 |
50 | MP0009745_abnormal_behavioral_response | 1.23814081 |
51 | MP0002254_reproductive_system_inflammat | 1.23664855 |
52 | MP0003183_abnormal_peptide_metabolism | 1.22059144 |
53 | MP0010386_abnormal_urinary_bladder | 1.22008514 |
54 | MP0004142_abnormal_muscle_tone | 1.20304126 |
55 | MP0003705_abnormal_hypodermis_morpholog | 1.19622507 |
56 | MP0001986_abnormal_taste_sensitivity | 1.17990570 |
57 | MP0002928_abnormal_bile_duct | 1.15354970 |
58 | MP0000015_abnormal_ear_pigmentation | 1.12600973 |
59 | MP0004924_abnormal_behavior | 1.12295891 |
60 | MP0005386_behavior/neurological_phenoty | 1.12295891 |
61 | MP0001486_abnormal_startle_reflex | 1.07452205 |
62 | MP0004484_altered_response_of | 1.05266181 |
63 | MP0002168_other_aberrant_phenotype | 1.04604177 |
64 | MP0000470_abnormal_stomach_morphology | 1.02776176 |
65 | MP0002064_seizures | 1.00568966 |
66 | MP0005671_abnormal_response_to | 0.98555022 |
67 | MP0002733_abnormal_thermal_nociception | 0.98325266 |
68 | MP0005636_abnormal_mineral_homeostasis | 0.97034330 |
69 | MP0001663_abnormal_digestive_system | 0.96730776 |
70 | MP0003787_abnormal_imprinting | 0.96069167 |
71 | MP0005645_abnormal_hypothalamus_physiol | 0.96015585 |
72 | MP0002876_abnormal_thyroid_physiology | 0.95656113 |
73 | MP0004043_abnormal_pH_regulation | 0.94462309 |
74 | MP0004147_increased_porphyrin_level | 0.93495563 |
75 | MP0001835_abnormal_antigen_presentation | 0.92621561 |
76 | MP0005381_digestive/alimentary_phenotyp | 0.91849974 |
77 | MP0003890_abnormal_embryonic-extraembry | 0.91213504 |
78 | MP0000685_abnormal_immune_system | 0.90841062 |
79 | MP0003656_abnormal_erythrocyte_physiolo | 0.89331804 |
80 | MP0003866_abnormal_defecation | 0.88179400 |
81 | MP0000598_abnormal_liver_morphology | 0.88155030 |
82 | MP0008004_abnormal_stomach_pH | 0.88129904 |
83 | MP0001970_abnormal_pain_threshold | 0.87829433 |
84 | MP0005448_abnormal_energy_balance | 0.87608026 |
85 | MP0002736_abnormal_nociception_after | 0.87274033 |
86 | MP0005387_immune_system_phenotype | 0.86705887 |
87 | MP0001790_abnormal_immune_system | 0.86705887 |
88 | MP0002067_abnormal_sensory_capabilities | 0.85895934 |
89 | MP0003186_abnormal_redox_activity | 0.85427736 |
90 | MP0001664_abnormal_digestion | 0.85052478 |
91 | MP0010678_abnormal_skin_adnexa | 0.84673594 |
92 | MP0002735_abnormal_chemical_nociception | 0.83793475 |
93 | MP0000538_abnormal_urinary_bladder | 0.83462230 |
94 | MP0009764_decreased_sensitivity_to | 0.83124814 |
95 | MP0010155_abnormal_intestine_physiology | 0.82876496 |
96 | MP0002272_abnormal_nervous_system | 0.82611443 |
97 | MP0005266_abnormal_metabolism | 0.82357235 |
98 | MP0001873_stomach_inflammation | 0.82346670 |
99 | MP0009379_abnormal_foot_pigmentation | 0.81544747 |
100 | MP0006082_CNS_inflammation | 0.81518090 |
101 | MP0009053_abnormal_anal_canal | 0.81344838 |
102 | MP0009642_abnormal_blood_homeostasis | 0.81285053 |
103 | MP0003879_abnormal_hair_cell | 0.81093568 |
104 | MP0000371_diluted_coat_color | 0.80047226 |
105 | MP0000604_amyloidosis | 0.79195057 |
106 | MP0008877_abnormal_DNA_methylation | 0.78826598 |
107 | MP0005376_homeostasis/metabolism_phenot | 0.76847444 |
108 | MP0002723_abnormal_immune_serum | 0.75751477 |
109 | MP0008872_abnormal_physiological_respon | 0.75004017 |
110 | MP0004145_abnormal_muscle_electrophysio | 0.74366458 |
111 | MP0003300_gastrointestinal_ulcer | 0.73418130 |
112 | MP0003718_maternal_effect | 0.73357352 |
113 | MP0006054_spinal_hemorrhage | 0.72069549 |
114 | MP0002796_impaired_skin_barrier | 0.71954345 |
115 | MP0002452_abnormal_antigen_presenting | 0.71824221 |
116 | MP0008469_abnormal_protein_level | 0.71759985 |
117 | MP0002572_abnormal_emotion/affect_behav | 0.71687605 |
118 | MP0005408_hypopigmentation | 0.71215573 |
119 | MP0002396_abnormal_hematopoietic_system | 0.71093353 |
120 | MP0009765_abnormal_xenobiotic_induced | 0.69370583 |
121 | MP0003633_abnormal_nervous_system | 0.68562899 |
122 | MP0009763_increased_sensitivity_to | 0.68462133 |
123 | MP0002638_abnormal_pupillary_reflex | 0.67323234 |
124 | MP0000477_abnormal_intestine_morphology | 0.66737805 |
125 | MP0003011_delayed_dark_adaptation | 0.66607676 |
126 | MP0004215_abnormal_myocardial_fiber | 0.65458222 |
127 | MP0002078_abnormal_glucose_homeostasis | 0.62801614 |
128 | MP0005647_abnormal_sex_gland | 0.59418509 |
129 | MP0005166_decreased_susceptibility_to | 0.56817215 |
130 | MP0002136_abnormal_kidney_physiology | 0.56239101 |
131 | MP0005334_abnormal_fat_pad | 0.55896878 |
132 | MP0005167_abnormal_blood-brain_barrier | 0.55835581 |
133 | MP0002971_abnormal_brown_adipose | 0.55800256 |
134 | MP0001756_abnormal_urination | 0.54612808 |
135 | MP0009384_cardiac_valve_regurgitation | 0.53006851 |
136 | MP0002132_abnormal_respiratory_system | 0.52668443 |
137 | MP0006036_abnormal_mitochondrial_physio | 0.50815488 |
138 | MP0003638_abnormal_response/metabolism_ | 0.49092179 |
139 | MP0008873_increased_physiological_sensi | 0.46145383 |
140 | MP0003878_abnormal_ear_physiology | 0.45531660 |
141 | MP0005377_hearing/vestibular/ear_phenot | 0.45531660 |
142 | MP0004947_skin_inflammation | 0.45077424 |
143 | MP0000467_abnormal_esophagus_morphology | 0.43893057 |
144 | MP0001765_abnormal_ion_homeostasis | 0.43457758 |
145 | MP0005535_abnormal_body_temperature | 0.42023160 |
146 | MP0003953_abnormal_hormone_level | 0.41720924 |
147 | MP0005464_abnormal_platelet_physiology | 0.41310972 |
148 | MP0005220_abnormal_exocrine_pancreas | 0.40998430 |
149 | MP0003453_abnormal_keratinocyte_physiol | 0.40538327 |
150 | MP0010368_abnormal_lymphatic_system | 0.39093477 |
151 | MP0004782_abnormal_surfactant_physiolog | 0.38887108 |
152 | MP0009115_abnormal_fat_cell | 0.37112830 |
153 | MP0000537_abnormal_urethra_morphology | 0.37056141 |
154 | MP0000230_abnormal_systemic_arterial | 0.36898199 |
155 | MP0000579_abnormal_nail_morphology | 0.35775848 |
156 | MP0002098_abnormal_vibrissa_morphology | 0.35501580 |
157 | MP0005248_abnormal_Harderian_gland | 0.34721779 |
158 | MP0005395_other_phenotype | 0.33895710 |
159 | MP0001845_abnormal_inflammatory_respons | 0.32358737 |
160 | MP0001881_abnormal_mammary_gland | 0.31748715 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypobetalipoproteinemia (HP:0003563) | 7.46164030 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.76122101 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.26692998 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.87864168 |
5 | Xanthomatosis (HP:0000991) | 5.87102132 |
6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.85657894 |
7 | Deep venous thrombosis (HP:0002625) | 5.62350719 |
8 | Genetic anticipation (HP:0003743) | 5.44047377 |
9 | Conjugated hyperbilirubinemia (HP:0002908) | 5.17855955 |
10 | Hyperventilation (HP:0002883) | 5.15367293 |
11 | Hypolipoproteinemia (HP:0010981) | 5.09030028 |
12 | Prolonged partial thromboplastin time (HP:0003645) | 5.02522223 |
13 | Fat malabsorption (HP:0002630) | 4.91291529 |
14 | Acanthocytosis (HP:0001927) | 4.55144302 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42638642 |
16 | Epidermoid cyst (HP:0200040) | 4.33619656 |
17 | Ileus (HP:0002595) | 4.31307445 |
18 | Hyperglycinuria (HP:0003108) | 4.30909826 |
19 | Hyperammonemia (HP:0001987) | 4.25492731 |
20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18006049 |
21 | Decreased circulating renin level (HP:0003351) | 4.16247355 |
22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.09964790 |
23 | Hyperlipoproteinemia (HP:0010980) | 4.05417568 |
24 | Complement deficiency (HP:0004431) | 3.95087699 |
25 | Progressive cerebellar ataxia (HP:0002073) | 3.94830279 |
26 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.91146457 |
27 | Malnutrition (HP:0004395) | 3.88256492 |
28 | Abnormality of glycine metabolism (HP:0010895) | 3.86066639 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86066639 |
30 | Pancreatic cysts (HP:0001737) | 3.81857327 |
31 | Protruding tongue (HP:0010808) | 3.76631330 |
32 | Hypercholesterolemia (HP:0003124) | 3.72706462 |
33 | Gaze-evoked nystagmus (HP:0000640) | 3.70152261 |
34 | Clumsiness (HP:0002312) | 3.67807822 |
35 | Hypoalphalipoproteinemia (HP:0003233) | 3.58817101 |
36 | Ketosis (HP:0001946) | 3.50621101 |
37 | Hypoglycemic coma (HP:0001325) | 3.50077478 |
38 | Congenital sensorineural hearing impairment (HP:0008527) | 3.43191044 |
39 | Abnormality of proline metabolism (HP:0010907) | 3.43158074 |
40 | Hydroxyprolinuria (HP:0003080) | 3.43158074 |
41 | Hyperglycinemia (HP:0002154) | 3.41366900 |
42 | Abnormality of the common coagulation pathway (HP:0010990) | 3.41342324 |
43 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.34226189 |
44 | Hyperbilirubinemia (HP:0002904) | 3.31293580 |
45 | Joint hemorrhage (HP:0005261) | 3.31255628 |
46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27572659 |
47 | Abnormality of methionine metabolism (HP:0010901) | 3.23371855 |
48 | Pancreatic fibrosis (HP:0100732) | 3.17606426 |
49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.14689583 |
50 | True hermaphroditism (HP:0010459) | 3.14612909 |
51 | Fair hair (HP:0002286) | 3.08607561 |
52 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.07765471 |
53 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06600274 |
54 | Metabolic acidosis (HP:0001942) | 3.02383460 |
55 | Poikilocytosis (HP:0004447) | 2.98822932 |
56 | Steatorrhea (HP:0002570) | 2.98090258 |
57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.96781053 |
58 | Abnormality of purine metabolism (HP:0004352) | 2.92787316 |
59 | Abnormality of complement system (HP:0005339) | 2.90869176 |
60 | Abnormality of the renal cortex (HP:0011035) | 2.90851326 |
61 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.85162668 |
62 | Ketoacidosis (HP:0001993) | 2.80028535 |
63 | Abnormality of renin-angiotensin system (HP:0000847) | 2.77687444 |
64 | Right ventricular cardiomyopathy (HP:0011663) | 2.75586123 |
65 | Congenital stationary night blindness (HP:0007642) | 2.75083352 |
66 | Metabolic alkalosis (HP:0200114) | 2.70832891 |
67 | Febrile seizures (HP:0002373) | 2.69370711 |
68 | Stomach cancer (HP:0012126) | 2.69173508 |
69 | Attenuation of retinal blood vessels (HP:0007843) | 2.69095801 |
70 | Generalized hypopigmentation of hair (HP:0011358) | 2.68764618 |
71 | Autoimmune thrombocytopenia (HP:0001973) | 2.60914465 |
72 | Chronic hepatic failure (HP:0100626) | 2.57964640 |
73 | Glycosuria (HP:0003076) | 2.56972299 |
74 | Abnormality of urine glucose concentration (HP:0011016) | 2.56972299 |
75 | Chronic diarrhea (HP:0002028) | 2.56295492 |
76 | Skin nodule (HP:0200036) | 2.52104956 |
77 | Hepatocellular carcinoma (HP:0001402) | 2.50320772 |
78 | Cystic liver disease (HP:0006706) | 2.49941114 |
79 | Tubular atrophy (HP:0000092) | 2.49636040 |
80 | Vascular calcification (HP:0004934) | 2.49427204 |
81 | Pigmentary retinal degeneration (HP:0001146) | 2.46968813 |
82 | Dicarboxylic aciduria (HP:0003215) | 2.46823294 |
83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46823294 |
84 | Hyperactive renin-angiotensin system (HP:0000841) | 2.46108868 |
85 | Lethargy (HP:0001254) | 2.41960576 |
86 | Abnormality of vitamin metabolism (HP:0100508) | 2.41425421 |
87 | Delayed CNS myelination (HP:0002188) | 2.40683569 |
88 | Dysmetric saccades (HP:0000641) | 2.40660891 |
89 | Abnormal gallbladder physiology (HP:0012438) | 2.40649122 |
90 | Cholecystitis (HP:0001082) | 2.40649122 |
91 | Increased cerebral lipofuscin (HP:0011813) | 2.40502883 |
92 | Molar tooth sign on MRI (HP:0002419) | 2.39211353 |
93 | Abnormality of midbrain morphology (HP:0002418) | 2.39211353 |
94 | Spontaneous abortion (HP:0005268) | 2.35064179 |
95 | Abnormality of serum amino acid levels (HP:0003112) | 2.31241046 |
96 | Inability to walk (HP:0002540) | 2.30530125 |
97 | Pancreatitis (HP:0001733) | 2.30211370 |
98 | Systemic lupus erythematosus (HP:0002725) | 2.28166654 |
99 | Abnormality of the renal medulla (HP:0100957) | 2.27810052 |
100 | Myocardial infarction (HP:0001658) | 2.27402526 |
101 | Optic neuritis (HP:0100653) | 2.26886857 |
102 | Retrobulbar optic neuritis (HP:0100654) | 2.26886857 |
103 | Abnormal gallbladder morphology (HP:0012437) | 2.26277590 |
104 | Absent speech (HP:0001344) | 2.25081784 |
105 | Hyperkalemia (HP:0002153) | 2.23418741 |
106 | Sensorimotor neuropathy (HP:0007141) | 2.23302263 |
107 | Cholelithiasis (HP:0001081) | 2.21533277 |
108 | Hypoglycemic seizures (HP:0002173) | 2.21024693 |
109 | Abdominal distention (HP:0003270) | 2.19740944 |
110 | Nephronophthisis (HP:0000090) | 2.19348062 |
111 | Cardiovascular calcification (HP:0011915) | 2.19071458 |
112 | Widely spaced teeth (HP:0000687) | 2.17108172 |
113 | Abolished electroretinogram (ERG) (HP:0000550) | 2.16776113 |
114 | Furrowed tongue (HP:0000221) | 2.15640941 |
115 | Late onset (HP:0003584) | 2.13565331 |
116 | Hypoplastic ischia (HP:0003175) | 2.13561398 |
117 | Irritability (HP:0000737) | 2.13411318 |
118 | Reticulocytosis (HP:0001923) | 2.13367696 |
119 | Orchitis (HP:0100796) | 2.12798200 |
120 | Progressive inability to walk (HP:0002505) | 2.11972284 |
121 | Large for gestational age (HP:0001520) | 2.11601648 |
122 | Amyloidosis (HP:0011034) | 2.11064875 |
123 | Cupped ribs (HP:0000887) | 2.10886232 |
124 | Increased mean platelet volume (HP:0011877) | 2.10687008 |
125 | Hypochromic microcytic anemia (HP:0004840) | 2.07264381 |
126 | Spastic diplegia (HP:0001264) | 2.07181981 |
127 | Esophageal varix (HP:0002040) | 2.07070769 |
128 | Abnormal cartilage morphology (HP:0002763) | 2.05328653 |
129 | Broad-based gait (HP:0002136) | 2.04243766 |
130 | Gout (HP:0001997) | 2.01831619 |
131 | Abnormality of potassium homeostasis (HP:0011042) | 2.01539716 |
132 | Abnormality of the ischium (HP:0003174) | 2.01438290 |
133 | Vomiting (HP:0002013) | 2.01391230 |
134 | Nephrolithiasis (HP:0000787) | 2.00646369 |
135 | Patellar aplasia (HP:0006443) | 1.99449470 |
136 | Proximal tubulopathy (HP:0000114) | 1.96626609 |
137 | Cerebral edema (HP:0002181) | 1.95751865 |
138 | Symptomatic seizures (HP:0011145) | 1.95345044 |
139 | Generalized aminoaciduria (HP:0002909) | 1.93781217 |
140 | Facial diplegia (HP:0001349) | 1.93741238 |
141 | Alkalosis (HP:0001948) | 1.93008379 |
142 | Abnormality of the gallbladder (HP:0005264) | 1.92920321 |
143 | Widely patent fontanelles and sutures (HP:0004492) | 1.91802417 |
144 | Chorioretinal atrophy (HP:0000533) | 1.91765779 |
145 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90144928 |
146 | Facial shape deformation (HP:0011334) | 1.89805773 |
147 | Potter facies (HP:0002009) | 1.89805773 |
148 | Medial flaring of the eyebrow (HP:0010747) | 1.89010940 |
149 | Hypoplastic labia majora (HP:0000059) | 1.88443415 |
150 | Nausea (HP:0002018) | 1.88348932 |
151 | Hematochezia (HP:0002573) | 1.88266626 |
152 | Glomerulonephritis (HP:0000099) | 1.88240911 |
153 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87965928 |
154 | Abnormality of alanine metabolism (HP:0010916) | 1.87965928 |
155 | Hyperalaninemia (HP:0003348) | 1.87965928 |
156 | Abnormality of chloride homeostasis (HP:0011422) | 1.87717772 |
157 | Abnormal tarsal ossification (HP:0008369) | 1.87243317 |
158 | Hyperaldosteronism (HP:0000859) | 1.85396044 |
159 | Rickets (HP:0002748) | 1.84848417 |
160 | Polycythemia (HP:0001901) | 1.84826714 |
161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83437213 |
162 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.82473323 |
163 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.81739284 |
164 | Abnormality of the nasal septum (HP:0000419) | 1.80671119 |
165 | Myositis (HP:0100614) | 1.80026932 |
166 | Abnormal biliary tract morphology (HP:0012440) | 1.78639647 |
167 | Congenital hepatic fibrosis (HP:0002612) | 1.78435148 |
168 | Abnormality of the labia majora (HP:0012881) | 1.76548650 |
169 | Preaxial foot polydactyly (HP:0001841) | 1.75659507 |
170 | Dialeptic seizures (HP:0011146) | 1.75470032 |
171 | Hypokalemia (HP:0002900) | 1.75388603 |
172 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.75340019 |
173 | Postural instability (HP:0002172) | 1.75330218 |
174 | Abnormality of T cell number (HP:0011839) | 1.74249803 |
175 | Poor coordination (HP:0002370) | 1.74043578 |
176 | Keratoconjunctivitis (HP:0001096) | 1.72696096 |
177 | Abnormal drinking behavior (HP:0030082) | 1.72497292 |
178 | Polydipsia (HP:0001959) | 1.72497292 |
179 | Abnormality of binocular vision (HP:0011514) | 1.71637566 |
180 | Diplopia (HP:0000651) | 1.71637566 |
181 | Macroglossia (HP:0000158) | 1.70363252 |
182 | Amelogenesis imperfecta (HP:0000705) | 1.69743748 |
183 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.69247928 |
184 | Absence seizures (HP:0002121) | 1.69084653 |
185 | Hemiplegia (HP:0002301) | 1.67935823 |
186 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.67108588 |
187 | Abnormality of the axillary hair (HP:0100134) | 1.66232515 |
188 | Abnormality of secondary sexual hair (HP:0009888) | 1.66232515 |
189 | Decreased central vision (HP:0007663) | 1.65457602 |
190 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.64698870 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 5.71686323 |
2 | ACVR1B | 5.43481131 |
3 | MST1R | 4.65963539 |
4 | LMTK2 | 4.06144559 |
5 | BCKDK | 3.70953875 |
6 | MST4 | 3.26453681 |
7 | ERN1 | 3.16171023 |
8 | ERBB4 | 2.77090732 |
9 | BMPR1B | 2.76426942 |
10 | GRK6 | 2.61397284 |
11 | FGFR4 | 2.44068218 |
12 | PRKG2 | 2.39236234 |
13 | SIK1 | 2.28334848 |
14 | TAOK3 | 2.13746161 |
15 | PTK6 | 2.01707617 |
16 | NME1 | 1.95977138 |
17 | RIPK1 | 1.92454702 |
18 | INSRR | 1.88497107 |
19 | MAP3K2 | 1.85196519 |
20 | ADRBK2 | 1.83914056 |
21 | OXSR1 | 1.82543631 |
22 | MAP2K2 | 1.78393858 |
23 | MAP3K10 | 1.77017329 |
24 | EPHA2 | 1.71875927 |
25 | AKT3 | 1.68551502 |
26 | NUAK1 | 1.66796591 |
27 | MET | 1.56545365 |
28 | MAPK11 | 1.51982284 |
29 | MAP2K6 | 1.50780036 |
30 | LATS1 | 1.47179741 |
31 | TXK | 1.41829631 |
32 | EPHB2 | 1.39208287 |
33 | STK39 | 1.37537755 |
34 | PKN2 | 1.29485234 |
35 | ADRBK1 | 1.27961129 |
36 | BLK | 1.27309198 |
37 | MAP3K3 | 1.26928083 |
38 | TBK1 | 1.24696836 |
39 | ERBB2 | 1.22751325 |
40 | TEC | 1.20404500 |
41 | PRKAA2 | 1.19565918 |
42 | WNK3 | 1.19325300 |
43 | MAP2K4 | 1.17168301 |
44 | CASK | 1.17114273 |
45 | TYK2 | 1.16488592 |
46 | NLK | 1.16230539 |
47 | MAP3K7 | 1.13944665 |
48 | PBK | 1.13662322 |
49 | IRAK1 | 1.13472217 |
50 | MYLK | 1.11445576 |
51 | TNIK | 1.09642482 |
52 | PIK3CG | 1.07181066 |
53 | MAPK13 | 1.06707049 |
54 | MKNK2 | 1.04974442 |
55 | SGK2 | 1.00852763 |
56 | TGFBR1 | 0.97970129 |
57 | PIK3CA | 0.97319092 |
58 | TRPM7 | 0.95552274 |
59 | PTK2B | 0.95316148 |
60 | WNK4 | 0.93541448 |
61 | NTRK3 | 0.93213901 |
62 | CAMKK2 | 0.90511537 |
63 | IRAK3 | 0.89644882 |
64 | WNK1 | 0.86935999 |
65 | MAP2K1 | 0.86363079 |
66 | MAP3K11 | 0.84948072 |
67 | MELK | 0.82059814 |
68 | MAP3K4 | 0.80382877 |
69 | CAMK1D | 0.79774958 |
70 | PTK2 | 0.79477082 |
71 | FLT3 | 0.77705224 |
72 | PINK1 | 0.75945916 |
73 | ITK | 0.75273387 |
74 | CAMK1G | 0.72798544 |
75 | EPHB1 | 0.70704880 |
76 | NEK9 | 0.70429234 |
77 | ABL2 | 0.69308814 |
78 | STK38 | 0.69069469 |
79 | BTK | 0.68640338 |
80 | PRKAA1 | 0.68153338 |
81 | STK24 | 0.66968895 |
82 | RIPK4 | 0.66954049 |
83 | STK11 | 0.66740711 |
84 | DAPK2 | 0.65230445 |
85 | MAP3K14 | 0.64531456 |
86 | GRK1 | 0.64526371 |
87 | JAK2 | 0.64514430 |
88 | BMX | 0.64319400 |
89 | TNK2 | 0.64182587 |
90 | MAP2K3 | 0.63701955 |
91 | IKBKE | 0.63563645 |
92 | CDK12 | 0.63497227 |
93 | KIT | 0.62158968 |
94 | PDPK1 | 0.61370568 |
95 | SYK | 0.61345877 |
96 | ZAK | 0.59873470 |
97 | CAMK2G | 0.59522213 |
98 | CDK6 | 0.59250785 |
99 | TESK1 | 0.58797016 |
100 | MAP4K1 | 0.58237545 |
101 | MAPK4 | 0.58112462 |
102 | PRKACG | 0.57910837 |
103 | SGK223 | 0.57713907 |
104 | SGK494 | 0.57713907 |
105 | STK10 | 0.56677247 |
106 | YES1 | 0.53280320 |
107 | CSK | 0.52711540 |
108 | PRKCE | 0.52581477 |
109 | PRKCZ | 0.51228565 |
110 | CHUK | 0.50437189 |
111 | SIK2 | 0.49470452 |
112 | BRD4 | 0.49377434 |
113 | TLK1 | 0.48646547 |
114 | TAOK1 | 0.47907373 |
115 | FER | 0.47352676 |
116 | KDR | 0.46330390 |
117 | SGK1 | 0.45882706 |
118 | MAPK15 | 0.45162451 |
119 | DYRK1B | 0.44959790 |
120 | CAMK4 | 0.44336067 |
121 | STK38L | 0.44247704 |
122 | MATK | 0.43967914 |
123 | IRAK4 | 0.43060355 |
124 | PRKCI | 0.42718453 |
125 | LCK | 0.42610209 |
126 | KSR2 | 0.42284624 |
127 | MAP3K1 | 0.42143682 |
128 | LYN | 0.41645719 |
129 | TIE1 | 0.40974140 |
130 | PDK2 | 0.40687358 |
131 | PRKCA | 0.40057513 |
132 | GSK3A | 0.39881412 |
133 | MAP4K2 | 0.39192884 |
134 | MAPKAPK3 | 0.39121769 |
135 | PAK3 | 0.38715087 |
136 | JAK1 | 0.38089500 |
137 | IKBKB | 0.37958165 |
138 | RPS6KA6 | 0.37951108 |
139 | MAP3K8 | 0.37682854 |
140 | HCK | 0.37193500 |
141 | PRKCQ | 0.36979682 |
142 | SGK3 | 0.36115290 |
143 | CDK19 | 0.35463182 |
144 | FGFR2 | 0.34961871 |
145 | PDGFRB | 0.33354883 |
146 | CAMK1 | 0.33346048 |
147 | PDK1 | 0.33213457 |
148 | MAPK7 | 0.33203839 |
149 | BRSK2 | 0.32996459 |
150 | RET | 0.32783840 |
151 | TRIB3 | 0.32295614 |
152 | ICK | 0.32143054 |
153 | PDK3 | 0.25222969 |
154 | PDK4 | 0.25222969 |
155 | STK3 | 0.24754688 |
156 | IGF1R | 0.24124438 |
157 | DDR2 | 0.23922216 |
158 | TESK2 | 0.23601549 |
159 | TTK | 0.21940256 |
160 | EPHA3 | 0.21627186 |
161 | FGFR3 | 0.18121312 |
162 | PRKCD | 0.14570122 |
163 | SRC | 0.14076758 |
164 | CSNK1A1 | 0.13803709 |
165 | PRKCB | 0.12675250 |
166 | EGFR | 0.11028040 |
Rank | Gene Set | Z-score |
---|---|---|
1 | African trypanosomiasis_Homo sapiens_hsa05143 | 5.51295363 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.53065781 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47491323 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05206535 |
5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.98679152 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.73783353 |
7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.54625125 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52557454 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39638283 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.36754004 |
11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.33419863 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28233652 |
13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.22525154 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.12979835 |
15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.11407197 |
16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.10988279 |
17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05695317 |
18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.98805659 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.98377901 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97682548 |
21 | Bile secretion_Homo sapiens_hsa04976 | 1.95665577 |
22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94600375 |
23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.89480767 |
24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88135714 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87774871 |
26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86934276 |
27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82438573 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81142348 |
29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77087737 |
30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76702862 |
31 | Peroxisome_Homo sapiens_hsa04146 | 1.76492670 |
32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71179724 |
33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67254978 |
34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.57117239 |
35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52837304 |
36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52095243 |
37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.49623600 |
38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.49444410 |
39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48621684 |
40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46321621 |
41 | Mineral absorption_Homo sapiens_hsa04978 | 1.38875435 |
42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.32531884 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30489492 |
44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29729962 |
45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28684842 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.28595926 |
47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28047732 |
48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26980799 |
49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26720028 |
50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26618918 |
51 | Galactose metabolism_Homo sapiens_hsa00052 | 1.21496936 |
52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20759808 |
53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20725172 |
54 | Taste transduction_Homo sapiens_hsa04742 | 1.17806633 |
55 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16148366 |
56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15036775 |
57 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14781043 |
58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08538846 |
59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08282453 |
60 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07952390 |
61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07603747 |
62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05753263 |
63 | Phototransduction_Homo sapiens_hsa04744 | 1.05748194 |
64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04807036 |
65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04686363 |
66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03125756 |
67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03087511 |
68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.01723720 |
69 | Morphine addiction_Homo sapiens_hsa05032 | 1.00478319 |
70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98887145 |
71 | Salivary secretion_Homo sapiens_hsa04970 | 0.98593950 |
72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97724222 |
73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97377947 |
74 | Asthma_Homo sapiens_hsa05310 | 0.94736453 |
75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94240905 |
76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93044034 |
77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92815429 |
78 | Renin secretion_Homo sapiens_hsa04924 | 0.88001009 |
79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86724402 |
80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86334858 |
81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85801959 |
82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85592429 |
83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.84855679 |
84 | Long-term depression_Homo sapiens_hsa04730 | 0.84703481 |
85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81932418 |
86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80446540 |
87 | Insulin secretion_Homo sapiens_hsa04911 | 0.79743528 |
88 | Allograft rejection_Homo sapiens_hsa05330 | 0.77208111 |
89 | Platelet activation_Homo sapiens_hsa04611 | 0.76855663 |
90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75303776 |
91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74707774 |
92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72872553 |
93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72488245 |
94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72185474 |
95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71719007 |
96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71449897 |
97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70890133 |
98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69225347 |
99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65390337 |
100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63557686 |
101 | Lysine degradation_Homo sapiens_hsa00310 | 0.63520388 |
102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61845107 |
103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57726973 |
104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56740585 |
105 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55809839 |
106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55625793 |
107 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54871470 |
108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53718494 |
109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52875397 |
110 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52859890 |
111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50792268 |
112 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.50479932 |
113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50164051 |
114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49650897 |
115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48223839 |
116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47358814 |
117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46944706 |
118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46092733 |
119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43327199 |
120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42334958 |
121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42191189 |
122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41985396 |
123 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41904660 |
124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41867431 |
125 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41777616 |
126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41322978 |
127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40450804 |
128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39889186 |
129 | Tuberculosis_Homo sapiens_hsa05152 | 0.39463375 |
130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35632467 |
131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31054415 |
132 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26938200 |
133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21515099 |
134 | Insulin resistance_Homo sapiens_hsa04931 | 0.13609915 |
135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.12187516 |
136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08933775 |
137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04241708 |
138 | Prion diseases_Homo sapiens_hsa05020 | 0.03199932 |
139 | Pertussis_Homo sapiens_hsa05133 | -0.1795997 |
140 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1747584 |
141 | Bladder cancer_Homo sapiens_hsa05219 | -0.1386020 |
142 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1369798 |
143 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1310097 |
144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1306919 |
145 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1243610 |
146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0945195 |
147 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0705556 |
148 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0666279 |
149 | Hepatitis C_Homo sapiens_hsa05160 | -0.0287205 |
150 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0274769 |
151 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0113613 |
152 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0110816 |